SFES
Safeguard Scientifics, Inc.
Price Chart
Latest Quote
$0.49
+0.00 (+0.00%)
Current Price
| Previous Close | $0.49 |
| Open | $0.39 |
| Day High | $0.39 |
| Day Low | $0.39 |
| Volume | 82 |
Stock Information
| Shares Outstanding | 16.72M |
| Total Debt | $1.25M |
| Cash Equivalents | $9.50M |
| Net Income | $-9.83M |
| Sector | Financial Services |
| Industry | Asset Management |
| Market Cap | $8.19M |
| EPS (TTM) | $-0.20 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $-68K |
| Income | $-9.83M |
| Book/sh | $1.20 |
| Cash/sh | $0.57 |
Financial Ratios
| Quick Ratio | 4.64 |
| Current Ratio | 4.84 |
| Debt/Eq | 6.25 |
Returns & Margins
| ROA | -11.74% |
| ROE | -36.03% |
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
| PEG | 1.35 |
| P/B | 0.41 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $nan |
| SMA50 | $nan |
| SMA200 | $nan |
| RSI | 66.67 |
| ATR | nan |
| Shares Float | 15.38M |
| Short Float | 1.61% |
| Short Ratio | 3.50 |
| Volatility | -0.94 |
| Rel Volume | 0.06 |
Performance History
| Week | nan% |
| Month | nan% |
| Quarter | nan% |
| 6 Months | nan% |
| YTD | nan% |
| Year | nan% |
| 3 Years | nan% |
| 5 Years | nan% |
| 10 Years | nan% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-15 | $nan | 82 |
| 2026-06-12 | $0.49 | 0 |
| 2026-06-11 | $0.49 | 1,000 |
| 2026-06-10 | $0.46 | 0 |
| 2026-06-09 | $0.46 | 100 |
| 2026-06-08 | $0.49 | 0 |
| 2026-06-05 | $0.49 | 0 |
| 2026-06-04 | $0.49 | 500 |
| 2026-06-03 | $0.49 | 2,500 |
| 2026-06-02 | $0.45 | 0 |
| 2026-06-01 | $0.45 | 200 |
| 2026-05-29 | $0.49 | 200 |
| 2026-05-28 | $0.49 | 8,600 |
| 2026-05-27 | $0.49 | 3,000 |
| 2026-05-26 | $0.42 | 0 |
| 2026-05-22 | $0.42 | 6,700 |
| 2026-05-21 | $0.39 | 0 |
| 2026-05-20 | $0.39 | 2,100 |
| 2026-05-19 | $0.44 | 1,300 |
| 2026-05-18 | $0.43 | 1,200 |
About Safeguard Scientifics, Inc.
Safeguard Scientifics, Inc. no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round. The firm prefers to make investments in companies engaged in the technology, financial services, and healthcare sector. Within the technology sector, it invests in software as a service, adtech / digital media, Internet of Everything, enhanced security, predictive analytics, machine learning, artificial intelligence, enterprise software, technology enabled services, internet/new media, financial technology, cloud, mobile, social, big data, in memory, and selected business services with capital requirements of up to $25 million. Within healthcare sector, the firm invests in molecular and point-of-care diagnostics, medical devices, regenerative medicine, medical technology, digital health, healthcare technology, specialty pharmaceuticals, and selected healthcare services. It invests throughout the United States with a focus on Mid-Atlantic region, and Southeastern Canada. The firm primarily invests between $5 million and $25 million in growth equity financing and between $5 million and $10 million in early-stage financing. It typically invests in the capital structures including owner financed and bootstrapped companies, corporate division or business unit, and venture capital-backed seeking a growth partner. The firm prefers to be the largest shareholder in its portfolio companies, with ownership in the range of 20 percent to 50 percent. However, it may occasionally take a majority or smaller stake in its portfolio companies. It prefers to invest in companies having proprietary technology and intellectual property. The firm prefers to take a Board seat in its portfolio companies. The company was founded in 1953 as Lancaster Corporation and changed its name to Safeguard Scientifics, Inc. in 1981. Safeguard Scientifics, Inc. is based in Radnor, Pennsylvania with additional office in Weston, Massachusetts.
Period:
Loading...
Income Statement (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Revenue | |||
| Total Revenue | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 |
| Expenses | |||
| Total Expenses | $5,683,000 | $4,775,000 | $7,153,000 |
| Other Income Expense | $-5,048,000 | $-10,282,000 | $33,881,000 |
| Other Non Operating Income Expenses | $2,037,000 | $-3,297,000 | $22,035,000 |
| Net Non Operating Interest Income Expense | $903,000 | $794,000 | $276,000 |
| Operating Expense | $5,683,000 | $4,775,000 | $7,153,000 |
| General And Administrative Expense | $5,683,000 | $4,775,000 | $7,153,000 |
| Income & Earnings | |||
| Net Income From Continuing Operation Net Minority Interest | $-9,828,000 | $-14,263,000 | $27,004,000 |
| Net Interest Income | $903,000 | $794,000 | $276,000 |
| Interest Income | $903,000 | $794,000 | $276,000 |
| Normalized Income | $-9,438,000 | $-19,890,000 | $7,858,000 |
| Net Income From Continuing And Discontinued Operation | $-9,828,000 | $-14,263,000 | $27,004,000 |
| Total Operating Income As Reported | $-5,683,000 | $-4,775,000 | $-7,153,000 |
| Net Income Common Stockholders | $-9,828,000 | $-14,263,000 | $27,004,000 |
| Net Income | $-9,828,000 | $-14,263,000 | $27,004,000 |
| Net Income Including Noncontrolling Interests | $-9,828,000 | $-14,263,000 | $27,004,000 |
| Net Income Continuous Operations | $-9,828,000 | $-14,263,000 | $27,004,000 |
| Pretax Income | $-9,828,000 | $-14,263,000 | $27,004,000 |
| Special Income Charges | $-390,000 | $5,627,000 | $19,146,000 |
| Earnings From Equity Interest | $-6,695,000 | $-12,612,000 | $-7,300,000 |
| Interest Income Non Operating | $903,000 | $794,000 | $276,000 |
| Operating Income | $-5,683,000 | $-4,775,000 | $-7,153,000 |
| Per Share | |||
| Diluted EPS | - | $-0.87 | $1.36 |
| Basic EPS | - | $-0.87 | $1.36 |
| Other | |||
| Tax Effect Of Unusual Items | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-4,974,000 | $-10,131,000 | $-26,070,000 |
| Total Unusual Items | $-390,000 | $5,627,000 | $19,146,000 |
| Total Unusual Items Excluding Goodwill | $-390,000 | $5,627,000 | $19,146,000 |
| Reconciled Depreciation | $319,000 | $271,000 | $229,000 |
| EBITDA (Bullshit earnings) | $-5,364,000 | $-4,504,000 | $-6,924,000 |
| EBIT | $-5,683,000 | $-4,775,000 | $-7,153,000 |
| Diluted NI Availto Com Stockholders | $-9,828,000 | $-14,263,000 | $27,004,000 |
| Tax Provision | $0 | $0 | $0 |
| Gain On Sale Of Business | $610,000 | $5,627,000 | $19,146,000 |
| Write Off | $1,000,000 | $0 | $0 |
| Selling General And Administration | $5,683,000 | $4,775,000 | $7,153,000 |
| Other Gand A | $5,683,000 | $4,775,000 | $7,153,000 |
| Diluted Average Shares | - | $16,337,000 | $19,827,000 |
| Basic Average Shares | - | $16,337,000 | $19,827,000 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Assets | |||
| Net Tangible Assets | $19,980,000 | $34,576,000 | $50,566,000 |
| Total Assets | $22,836,000 | $37,692,000 | $54,028,000 |
| Total Non Current Assets | $12,925,000 | $16,269,000 | $23,750,000 |
| Other Non Current Assets | $263,000 | $434,000 | $217,000 |
| Current Assets | $9,911,000 | $21,423,000 | $30,278,000 |
| Other Current Assets | $394,000 | $1,251,000 | $965,000 |
| Restricted Cash | $19,000 | $25,000 | $25,000 |
| Cash Cash Equivalents And Short Term Investments | $9,498,000 | $20,147,000 | $29,288,000 |
| Cash And Cash Equivalents | $9,498,000 | $13,331,000 | $24,739,000 |
| Prepaid Assets | - | - | $965,000 |
| Debt | |||
| Total Debt | $1,249,000 | $1,678,000 | $2,053,000 |
| Long Term Debt And Capital Lease Obligation | $760,000 | $1,249,000 | $1,678,000 |
| Current Debt And Capital Lease Obligation | $489,000 | $429,000 | $375,000 |
| Liabilities | |||
| Total Liabilities Net Minority Interest | $2,856,000 | $3,116,000 | $3,462,000 |
| Total Non Current Liabilities Net Minority Interest | $810,000 | $1,299,000 | $1,728,000 |
| Other Non Current Liabilities | $50,000 | $50,000 | $50,000 |
| Current Liabilities | $2,046,000 | $1,817,000 | $1,734,000 |
| Payables And Accrued Expenses | $703,000 | $881,000 | $565,000 |
| Payables | $107,000 | $16,000 | $41,000 |
| Accounts Payable | $107,000 | $16,000 | $41,000 |
| Equity | |||
| Common Stock Equity | $19,980,000 | $34,576,000 | $50,566,000 |
| Total Equity Gross Minority Interest | $19,980,000 | $34,576,000 | $50,566,000 |
| Stockholders Equity | $19,980,000 | $34,576,000 | $50,566,000 |
| Gains Losses Not Affecting Retained Earnings | $-25,000 | $-25,000 | $-25,000 |
| Other Equity Adjustments | $-25,000 | $-25,000 | $-25,000 |
| Retained Earnings | $-733,726,000 | $-723,898,000 | $-709,635,000 |
| Other | |||
| Treasury Shares Number | $4,947,000 | $5,478,000 | $5,068,000 |
| Ordinary Shares Number | $16,626,000 | $16,095,000 | $16,505,000 |
| Share Issued | $21,573,000 | $21,573,000 | $21,573,000 |
| Tangible Book Value | $19,980,000 | $34,576,000 | $50,566,000 |
| Invested Capital | $19,980,000 | $34,576,000 | $50,566,000 |
| Working Capital | $7,865,000 | $19,606,000 | $28,544,000 |
| Capital Lease Obligations | $1,249,000 | $1,678,000 | $2,053,000 |
| Total Capitalization | $19,980,000 | $34,576,000 | $50,566,000 |
| Treasury Stock | $42,418,000 | $48,410,000 | $48,569,000 |
| Additional Paid In Capital | $793,992,000 | $804,752,000 | $806,638,000 |
| Capital Stock | $2,157,000 | $2,157,000 | $2,157,000 |
| Common Stock | $2,157,000 | $2,157,000 | $2,157,000 |
| Preferred Stock | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $760,000 | $1,249,000 | $1,678,000 |
| Current Capital Lease Obligation | $489,000 | $429,000 | $375,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $854,000 | $507,000 | $794,000 |
| Current Accrued Expenses | $596,000 | $865,000 | $524,000 |
| Investments And Advances | $11,691,000 | $14,545,000 | $21,972,000 |
| Net PPE | $971,000 | $1,290,000 | $1,561,000 |
| Gross PPE | $971,000 | $1,290,000 | $1,561,000 |
| Other Properties | $971,000 | $1,290,000 | - |
| Other Short Term Investments | $0 | $6,816,000 | $4,549,000 |
| Buildings And Improvements | - | $1,290,000 | $1,561,000 |
| Properties | - | $0 | $0 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Free Cash Flow | |||
| Free Cash Flow | $-3,308,000 | $-3,258,000 | $-8,152,000 |
| Operating Activities | |||
| Operating Cash Flow | $-3,308,000 | $-3,258,000 | $-8,152,000 |
| Cash Flow From Continuing Operating Activities | $-3,308,000 | $-3,258,000 | $-8,152,000 |
| Operating Gains Losses | $5,543,000 | $10,674,000 | $-27,875,000 |
| Investing Activities | |||
| Investing Cash Flow | $5,721,000 | $-4,662,000 | $58,114,000 |
| Cash Flow From Continuing Investing Activities | $5,721,000 | $-4,662,000 | $58,114,000 |
| Net Other Investing Changes | $-250,000 | $-5,670,000 | $-2,718,000 |
| Financing Activities | |||
| Repurchase Of Capital Stock | $-75,000 | $-2,939,000 | $-40,655,000 |
| Financing Cash Flow | $-6,252,000 | $-3,488,000 | $-40,799,000 |
| Cash Flow From Continuing Financing Activities | $-6,252,000 | $-3,488,000 | $-40,799,000 |
| Net Other Financing Charges | $-358,000 | $-549,000 | $-144,000 |
| Cash Dividends Paid | $-5,819,000 | $0 | - |
| Common Stock Dividend Paid | $-5,819,000 | $0 | - |
| Net Common Stock Issuance | $-75,000 | $-2,939,000 | $-40,655,000 |
| Other | |||
| End Cash Position | $9,517,000 | $13,356,000 | $24,764,000 |
| Beginning Cash Position | $13,356,000 | $24,764,000 | $15,601,000 |
| Changes In Cash | $-3,839,000 | $-11,408,000 | $9,163,000 |
| Common Stock Payments | $-75,000 | $-2,939,000 | $-40,655,000 |
| Net Investment Purchase And Sale | $6,120,000 | $-5,871,000 | $0 |
| Sale Of Investment | $14,650,000 | $6,000,000 | $0 |
| Purchase Of Investment | $-8,530,000 | $-11,871,000 | $0 |
| Net Business Purchase And Sale | $-149,000 | $6,879,000 | $60,832,000 |
| Sale Of Business | $2,851,000 | $6,879,000 | $60,832,000 |
| Purchase Of Business | $-3,000,000 | $0 | $0 |
| Change In Working Capital | $32,000 | $-908,000 | $-3,283,000 |
| Change In Payables And Accrued Expense | $178,000 | $-374,000 | $-3,045,000 |
| Change In Payable | $178,000 | $-374,000 | $-3,045,000 |
| Change In Account Payable | $178,000 | $-374,000 | $-3,045,000 |
| Change In Prepaid Assets | $-146,000 | $-534,000 | $-238,000 |
| Other Non Cash Items | $-7,000 | $76,000 | $-22,000 |
| Stock Based Compensation | $1,121,000 | $1,445,000 | $1,779,000 |
| Unrealized Gain Loss On Investment Securities | $-1,661,000 | $-553,000 | $-8,505,000 |
| Asset Impairment Charge | $1,173,000 | $0 | $2,521,000 |
| Depreciation Amortization Depletion | $319,000 | $271,000 | $229,000 |
| Depreciation And Amortization | $319,000 | $271,000 | $229,000 |
| Depreciation | $319,000 | $271,000 | $229,000 |
| Earnings Losses From Equity Investments | $6,085,000 | $10,674,000 | $7,409,000 |
| Gain Loss On Sale Of Business | $-542,000 | $0 | $-35,284,000 |
| Net Income From Continuing Operations | $-9,828,000 | $-14,263,000 | $27,004,000 |
Fetched: 2026-02-02